Prosecution Insights
Last updated: April 19, 2026

Supernus Pharmaceuticals, Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
1
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18740059 DERIVATIVES OF SUBSTITUTED MORPHOLINES AND USES THEREOF TRAN, ERIC 1629 Non-Final OA Jun 11, 2024
17991697 OSMOTIC DRUG DELIVERY SYSTEM TRAN, SUSAN T 1615 Non-Final OA Nov 21, 2022
17358920 STABILIZED FORMULATIONS OF CNS COMPOUNDS THOMAS, TIMOTHY P 1614 Non-Final OA Jun 25, 2021
16297194 FORMULATIONS OF VILOXAZINE PEEBLES, KATHERINE 1617 Final Rejection Mar 08, 2019

Managing Supernus Pharmaceuticals, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month